Company Profile

BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.

Employees

236

Sector

Pharmaceuticals

More about the company

27/07/21	Taisho Pharmaceutical Holdings Co., Ltd. completed the acquisition of remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers.	CI
14/05/21	Taisho Pharmaceutical Holdings Co., Ltd. executed a share exchange agreement to acquire remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers for ¥14.8 billion.	CI
18/09/17	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	CI
02/02/17	Taisho and Takeda Terminate Agreement on the Distribution of Biofermin Pharmaceutical's OTC Drugs and Quasi-Drugs	CI
19/09/16	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index	CI
21/09/15	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	CI
01/08/13	Takeda Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. Agrees Conduct Domestic Transactions in Relation to Sale of Products Manufactured by Biofermin Pharmaceutical	CI
31/07/13	Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. from Takeda Pharmaceutical Company Limited.	CI
25/07/13	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to Japan TOPIX Index	CI

Manager	Title	Age	Since
Toshimichi Kunori PSD	President	55	01/04/2021
Hidehiko Kitamura IRC	Investor Relations Contact	62	01/10/2019

Director	Title	Age	Since
Hideyuki Waki BRD	Director/Board Member	83	01/06/2008
Ken Uehara CHM	Chairman	48	01/06/2017
Toru Kawasaki BRD	Director/Board Member	76	24/06/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOFERMIN PHARMACEUTICAL CO., LTD.	-0.79%	+0.81%	-	-	342M
ELI LILLY AND COMPANY	+1.08%	-3.93%	+48.03%	+160.13%	1,043B
JOHNSON & JOHNSON	+1.19%	-3.52%	+51.70%	+56.36%	602B
ABBVIE INC.	+4.21%	+1.79%	+33.48%	+87.04%	449B
ROCHE HOLDING AG	+0.42%	-1.16%	+29.43%	+22.27%	327B
NOVARTIS AG	+1.03%	-0.84%	+29.58%	+45.08%	279B
ASTRAZENECA PLC	+0.49%	-5.44%	+21.00%	+22.32%	264B
AMGEN INC.	+3.70%	+2.19%	+24.27%	+63.38%	201B
GILEAD SCIENCES, INC.	+3.49%	+1.08%	+24.08%	+76.58%	169B
PFIZER INC.	+1.29%	+3.67%	+2.15%	-30.78%	143B
Average	+1.34%	-0.68%	+29.30%	+55.82%	386.34B
Weighted average by Cap.	+1.67%	-1.82%	+37.08%	+82.54%

Biofermin Pharmaceutical Co., Ltd. Stock

Stocks

4517

JP3799800002

Pharmaceuticals

Latest news : Biofermin Pharmaceutical Co., Ltd.

Quotes and Performance

Managers and Directors: Biofermin Pharmaceutical Co., Ltd.

Other Pharmaceuticals

Company Profile